The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma

miR-BART22, a new discovered Epstein-Barr virus (EBV) miRNA, is abundant in Nasopharyngeal carcinoma (NPC). It has been reported that miR-BART22 promoted the tumor development by down-modulating EBV LMP2 expression to evade the host immune response. But its cell target genes have still been obscure....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruichao, Zhang, Minfeng, Li, Qiulian, Xiong, Hanzhen, Liu, Shaoyan, Fang, Weiyi, Zhang, Qianbing, Liu, Zhen, Xu, Xuehu, Jiang, Qingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327380/
https://www.ncbi.nlm.nih.gov/pubmed/28243335
http://dx.doi.org/10.7150/jca.15753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327380/
https://www.ncbi.nlm.nih.gov/pubmed/28243335
http://dx.doi.org/10.7150/jca.15753

Ejemplares similares